FOXO Share Price Performance
Recent FOXO News & Updates
No updates
FOXO Technologies Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -1.24
- Gross Margin
- 39.17%
- Net Profit Margin
- -173.34%
- Debt/Equity Ratio
- 62.2%
FOXO Technologies Inc. Competitors
About FOXO
- Founded
- 2020
- Employees
- 135
- CEO
- WebsiteView website
FOXO Technologies Inc. operates as a healthcare services and technology company in the United States. The company operates through two segments: Healthcare and Labs and Life. The company offers behavioural health; ancillary, including laboratory, radiology, respiratory, and pharmacy; insurance; and other services. The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and Bioinformatics services that provides data solutions using AI and machine learning for data analysis and processing, and quality checking for academia, healthcare, government, and pharmaceutical research customers. FOXO Technologies Inc. was founded in 2020 and is based in West Palm Beach, Florida.
U.S. Market Performance
- 7 Days: 1.4%
- 3 Months: 16.3%
- 1 Year: 17.3%
- Year to Date: 8.7%
The market has climbed by 1.4% over the past week, with every sector up and the Healthcare sector leading the way. The market is up 17% over the last 12 months. Earnings are forecast to grow by 15% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading